News

Tuesday, 6 July 2010 - 15:47

TAC is saddened by the loss of our long standing comrade, Vuyani Jacobs. Vuyani joined TAC after being diagnosed with HIV while working in the Eastern Cape. He later moved to Cape Town and worked as an organizer for TAC. Vuyani continued to fight for the rights of people living with HIV at Community Media Trust, where he became the Deputy Director. Vuyani was an activist, brother, colleague, mentor and friend to many of us.

 

 

TAC is saddened by the loss of our long standing comrade, Vuyani Jacobs. Vuyani joined TAC after being diagnosed with HIV while working in...

Read more
Thursday, 1 July 2010 - 20:56

On 19 May 2010, the North Gauteng High Court handed down its judgment in this case which considered a challenge by Aurobindo – a local subsidiary of a major Indian-based generics manufacturer – to its disqualification from participating in the 2008 efavirenz tender. Efavirenz is a key ARV medicine that is used by over two-thirds of people accessing ARV treatment in the public sector.

In his judgment, Justice Prinsloo came to the conclusion “that there was a lack of procedural fairness in the process”.[2] In other words, Aurobindo should not have been disqualified from participating...

Read more
Thursday, 1 July 2010 - 20:47

During the 1990s and early 2000s generic competition drove down the prices of ARVs. Without these massive price reductions, nearly a million additional people would be dead or dying now in South Africa. In 2005 many generic producing countries, including India, became TRIPS compliant. This means that medicines developed since 1995 cannot as easily be produced by generic companies operating in India.

Pressure is being applied by the European Union on the Indian government to sign a bilateral trade agreement that will further stifle competition on essential medicines still under...

Read more
Thursday, 1 July 2010 - 20:09

Ubhejane is marketed by a charlatan named Zeblon Gwala as a cure for AIDS. On 22 June 2010 it was incorrectly reported in Business Report that Ubhejane was registered with the Medicines Control Council (MCC). Ubhejane has not been registered as a medicine in South Africa. There is no evidence that it is of any benefit to people with HIV.

Ubhejane is not registered
Department of Health's Law Enforcement Unit must investigate Zeblon Gwala
MCC's recission of the 2002 notice must be given immediate effect

Ubhejane is marketed by...

Read more

Pages